Ruidong Li

1.5k total citations · 2 hit papers
32 papers, 1.1k citations indexed

About

Ruidong Li is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Ruidong Li has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Immunology and 6 papers in Epidemiology. Recurrent topics in Ruidong Li's work include Inflammasome and immune disorders (7 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Immune cells in cancer (4 papers). Ruidong Li is often cited by papers focused on Inflammasome and immune disorders (7 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Immune cells in cancer (4 papers). Ruidong Li collaborates with scholars based in China, United States and Czechia. Ruidong Li's co-authors include Kaixiong Tao, Yuping Yin, Wenchang Yang, Liang Shi, Yaxin Wang, Yongzhou Huang, Chengguo Li, Jiaxian Yu, Peng Zhang and Weizhen Liu and has published in prestigious journals such as Scientific Reports, Free Radical Biology and Medicine and Molecules.

In The Last Decade

Ruidong Li

30 papers receiving 1.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Maresin1 Protect Against Ferroptosis-Induced Liver Injury Through ROS Inhibition and Nrf2/HO-1/GPX4 Activation

2022 145 citations Wenchang Yang, Yaxin Wang et al. Frontiers in Pharmacology profile →
4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to promote cuproptosis in colorectal cancer

2023 124 citations Wenchang Yang, Yaxin Wang et al. Biomedicine & Pharmacotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ruidong Li China	20	618	240	197	183	181	32	1.1k
Jing Qi China	17	490 0.8×	109 0.5×	181 0.9×	198 1.1×	221 1.2×	40	996
Yuping Yin China	26	798 1.3×	392 1.6×	324 1.6×	290 1.6×	337 1.9×	63	1.6k
Sabine M. Klauck Germany	20	955 1.5×	137 0.6×	142 0.7×	155 0.8×	171 0.9×	58	1.6k
Ruizhi Tan China	21	716 1.2×	188 0.8×	149 0.8×	179 1.0×	89 0.5×	73	1.4k
Palanisamy Nallasamy United States	21	670 1.1×	282 1.2×	108 0.5×	275 1.5×	330 1.8×	38	1.5k
Lizhu Lin China	19	633 1.0×	106 0.4×	177 0.9×	202 1.1×	255 1.4×	75	1.2k
Xin Dong China	21	549 0.9×	88 0.4×	195 1.0×	176 1.0×	365 2.0×	68	1.3k
Srinivasan Kalayarasan India	18	504 0.8×	149 0.6×	255 1.3×	85 0.5×	156 0.9×	20	1.2k
Xiaodong Xu China	18	645 1.0×	214 0.9×	157 0.8×	260 1.4×	273 1.5×	59	1.2k

Countries citing papers authored by Ruidong Li

Since Specialization

Citations

This map shows the geographic impact of Ruidong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruidong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruidong Li more than expected).

Fields of papers citing papers by Ruidong Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruidong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruidong Li. The network helps show where Ruidong Li may publish in the future.

Co-authorship network of co-authors of Ruidong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Ruidong Li. A scholar is included among the top collaborators of Ruidong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruidong Li. Ruidong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zeng, Liwu, Yaxin Wang, Yongzhou Huang, et al.. (2025). IRG1/itaconate enhances efferocytosis by activating Nrf2-TIM4 signaling pathway to alleviate con A induced autoimmune liver injury. Cell Communication and Signaling. 23(1). 63–63. 5 indexed citations

Zhou, Pei, Lei Yang, Hang Li, et al.. (2024). IRG1/Itaconate inhibits hepatic stellate cells ferroptosis and attenuates TAA-induced liver fibrosis by regulating SLC39A14 expression. International Immunopharmacology. 146. 113945–113945.

Zhou, Pei, Lei Yang, Ruidong Li, et al.. (2024). IRG1/itaconate alleviates acute liver injury in septic mice by suppressing NLRP3 expression and its mediated macrophage pyroptosis via regulation of the Nrf2 pathway. International Immunopharmacology. 135. 112277–112277. 13 indexed citations

Yang, Wenchang, Yaxin Wang, Yongzhou Huang, et al.. (2023). Immune Response Gene-1 [IRG1]/itaconate protect against multi-organ injury via inhibiting gasdermin D-mediated pyroptosis and inflammatory response. Inflammopharmacology. 32(1). 419–432. 18 indexed citations

Yang, Wenchang, Yaxin Wang, Yongzhou Huang, et al.. (2023). 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to promote cuproptosis in colorectal cancer. Biomedicine & Pharmacotherapy. 159. 114301–114301. 124 indexed citations breakdown →

Rogers, Mary Rose, Wei Zeng, Xian Zhang, et al.. (2023). Bone Morphogenic Protein 9 (BMP9)/Growth Differentiation Factor 2 (GDF2) modulates mouse adult hippocampal neurogenesis by regulating the survival of early neural progenitors. Genes & Diseases. 10(4). 1175–1179.

Yang, Wenchang, Kaixiong Tao, Yaxin Wang, et al.. (2022). Necrosulfonamide ameliorates intestinal inflammation via inhibiting GSDMD-medicated pyroptosis and MLKL-mediated necroptosis. Biochemical Pharmacology. 206. 115338–115338. 52 indexed citations

Wang, Tao, Peng Zhang, Chengguo Li, et al.. (2022). MUS81 Inhibition Enhances the Anticancer Efficacy of Talazoparib by Impairing ATR/CHK1 Signaling Pathway in Gastric Cancer. Frontiers in Oncology. 12. 844135–844135. 9 indexed citations

Yang, Wenchang, Yaxin Wang, Tao Wang, et al.. (2022). Protective effects of IRG1/itaconate on acute colitis through the inhibition of gasdermins-mediated pyroptosis and inflammation response. Genes & Diseases. 10(4). 1552–1563. 32 indexed citations

10.

Li, Ruidong, Wenchang Yang, Yuping Yin, et al.. (2021). 4-OI Attenuates Carbon Tetrachloride-Induced Hepatic Injury via Regulating Oxidative Stress and the Inflammatory Response. Frontiers in Pharmacology. 12. 651444–651444. 45 indexed citations

11.

Yang, Wenchang, Kaixiong Tao, Peng Zhang, et al.. (2021). Maresin 1 protects against lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting macrophage pyroptosis and inflammatory response. Biochemical Pharmacology. 195. 114863–114863. 72 indexed citations

12.

Li, Chengguo, Qian Shen, Peng Zhang, et al.. (2021). Targeting MUS81 promotes the anticancer effect of WEE1 inhibitor and immune checkpoint blocking combination therapy via activating cGAS/STING signaling in gastric cancer cells. Journal of Experimental & Clinical Cancer Research. 40(1). 315–315. 31 indexed citations

13.

Zhang, Peng, Yuping Yin, Tao Wang, et al.. (2019). Maresin 1 mitigates concanavalin A-induced acute liver injury in mice by inhibiting ROS-mediated activation of NF-κB signaling. Free Radical Biology and Medicine. 147. 23–36. 60 indexed citations

14.

Zhang, Peng, Ruidong Li, Hua Xiao, et al.. (2019). BRD4 Inhibitor AZD5153 Suppresses the Proliferation of Colorectal Cancer Cells and Sensitizes the Anticancer Effect of PARP Inhibitor. International Journal of Biological Sciences. 15(9). 1942–1954. 44 indexed citations

15.

Bai, Jie, Weilong Chang, Gengchen Xie, et al.. (2016). Monoacylglycerol lipase inhibitor JZL184 regulates apoptosis and migration of colorectal cancer cells. Molecular Medicine Reports. 13(3). 2850–2856. 30 indexed citations

16.

Li, Ruidong, Yaxin Wang, Ende Zhao, et al.. (2016). Maresin 1, a Proresolving Lipid Mediator, Mitigates Carbon Tetrachloride‐Induced Liver Injury in Mice. Oxidative Medicine and Cellular Longevity. 2016(1). 9203716–9203716. 65 indexed citations

17.

Wang, Yaxin, Ruidong Li, Lin Chen, et al.. (2015). Maresin 1 Inhibits Epithelial-to-Mesenchymal Transition in Vitro and Attenuates Bleomycin Induced Lung Fibrosis in Vivo. Shock. 44(5). 496–502. 33 indexed citations

18.

Guo, Wenyuan, et al.. (2011). The protective effects of ginkgo leaf extract on CCl 4 -induced liver injury in mice. Journal of Medicinal Plants Research. 5(11). 2361–2364. 4 indexed citations

19.

Guo, Wenyuan, et al.. (2011). Inhibition of Lentinus edodes polysaccharides against liver tumour growth. International Journal of the Physical Sciences. 6(1). 116–120. 6 indexed citations

20.

Li, Ruidong, et al.. (2011). Hepatoprotective Action of Radix Paeoniae Rubra Aqueous Extract against CCl4-Induced Hepatic Damage. Molecules. 16(10). 8684–8693. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact